Copyright
©The Author(s) 2018.
World J Hepatol. May 27, 2018; 10(5): 417-424
Published online May 27, 2018. doi: 10.4254/wjh.v10.i5.417
Published online May 27, 2018. doi: 10.4254/wjh.v10.i5.417
Malignancy (n = 21) | Inflammatory state (n = 28) | Medications (n = 19) | Not specified (n = 20) | Total | P | |
Zone III II and III I, II, and III Other | 0.82 | |||||
17 (81) 1 (5) 1 (5) 2 (10) | 22 (79) 3 (11) 0 (0) 3 (11) | 16 (84) 1 (5) 1 (5) 1 (5) | 14 (70) 3 (15) 0 (0) 3 (15) | 69 8 2 9 | ||
METAVIR score | 0.60 | |||||
0 | 15 (71) 3 (14) 1 (5) 0 (0) | 14 (50) 6 (21) 4 (14) 1 (4) | 13 (68) 3 (16) 1 (5) 2 (11) | 9 (45) 5 (25) 3 (15) 2 (10) | 51 17 9 5 | |
1 | ||||||
2 | ||||||
3 | ||||||
Nodular regenerative hyperplasia | 1(5) | 2 (7) | 4 (21) | 2 (10) | 9 | 0.33 |
Hepatic peliosis | 1 (5) | 0 | 0 | 0 | 1 | 0.36 |
Lymphocytic infiltration | 6 (29) | 8 (29) | 6 (32) | 4(20) | 24 | 0.77 |
RBC extravasation | 8 (38) | 8 (29) | 7 (37) | 5 (25) | 28 | 0.76 |
Hepatocellular plate atrophy | 11 (52) | 21 (75) | 8 (42) | 11 (55) | 51 | 0.13 |
- Citation: Sunjaya DB, Ramos GP, Braga Neto MB, Lennon R, Mounajjed T, Shah V, Kamath PS, Simonetto DA. Isolated hepatic non-obstructive sinusoidal dilatation, 20-year single center experience. World J Hepatol 2018; 10(5): 417-424
- URL: https://www.wjgnet.com/1948-5182/full/v10/i5/417.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i5.417